Taipei, Taiwan — Founded 2025 台北,台灣 — 創立於 2025

The First Point-of-Care 第一個即時照護端的Alzheimer's阿茲海默症 Blood Screening血液篩檢

Accura is building a rapid plasma biomarker test that brings Alzheimer's disease screening from centralized laboratories to the communities where patients live 東健科技正在開發一項快速血漿生物標記檢測,將阿茲海默症篩檢從中央實驗室帶入患者所在的社區

What We Do 我們做什麼

Making early Alzheimer's detection accessible — everywhere 讓阿茲海默症的早期檢測 — 觸手可及

Our Alzcheck system quantifies pTau181 from a small plasma sample in approximately 14 minutes — compact enough for a primary care desk, precise enough for clinical decisions 我們的 Alzcheck 系統能在約 14 分鐘內從少量血漿定量 pTau181 — 精巧到可以放在基層診所桌上,精準到足以輔助臨床決策

~14 min
Sample to result 從樣本到結果
100 µL
Plasma required 所需血漿量
2–30°C
Ambient storage, no cold chain 常溫儲存,免冷鏈
"Every patient with cognitive concerns can access biomarker testing — right in their doctor's office" 「每一個有認知疑慮的患者都能夠接受生物標記檢測 — 就在熟悉的診所」
The vision behind Accura 東健科技的創立願景
Get in Touch 與我們聯繫

Let's talk 歡迎洽談

Clinicians, investors, and partners — we'd welcome the conversation 醫療專業人員、投資人與合作夥伴 — 我們期待與您對話

info@accura.com.tw

2F-6, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei, Taiwan 115022115022 台北市南港區忠孝東路七段508號2樓之6